---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-013132"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:18:02.285345+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Processa CEO presents at MedInvest conference; no specific material data in filing

## Summary
- CEO George Ng presented at MedInvest Biotech + Pharma Investor Conference on April 3, 2024 in NYC.
- Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' was at 10:55 AM ET.
- President R&D David Young attended the meeting virtually.
- Presentation furnished as Exhibit 99.1 but not included in this filing; no numbers or clinical data disclosed.
- Company directs investors to website for presentation and routine disclosure.

## SEC filing metadata
- accession: 0001493152-24-013132
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315224013132/0001493152-24-013132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315224013132/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-013132
- JSON: https://secwatch.observer/filing/0001493152-24-013132.json
- Plain text: https://secwatch.observer/filing/0001493152-24-013132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.